TABLE 3.
Characteristics, of variables used in the models, of patients, > 17, admitted to Swedish ICUs, with COVID‐19, between 6th of March and 27th of May 2020
| ICU admitted cohort | ICU discharged cohort | P | Not yet ICU discharged patients | |
|---|---|---|---|---|
| Number of patients | 1981 | 1544 | 437 | |
| Age | 61 (52‐69) | 60 (51‐69) | .11 | 62 (54‐69) |
| SAPS3 | 53 (46‐69) | 53 (46‐59) | .91 | 53 (46‐59) |
| Female sex | 516 (26) | 419 (27.1) | .042 | 97 (22.2) |
| Ischemic heart disease | 142 (7.2) | 99 (6.4) | .020 | 43 (9.8) |
| Non‐ischemic heart disease | 175 (8.8) | 129 (8.4) | .18 | 46 (10.4) |
| Hypertension | 982 (49.6) | 750 (48.6) | .10 | 232 (53.1) |
| Type 1 diabetes mellitus | 40 (2.0) | 31 (2.0) | 1.00 | 9 (2.1) |
| Type 2 diabetes mellitus | 482 (24.3) | 369 (23.9) | .41 | 113 (25.9) |
| Stroke | 59 (3.0) | 47 (3.0) | .87 | 12 (2.7) |
| Chronic renal failure | 75 (3.8) | 55 (3.6) | .39 | 20 (4.6) |
| COPD | 75 (3.8) | 56 (3.6) | .48 | 19 (4.3) |
| Asthma | 133 (6.7) | 105 (6.8) | .83 | 28 (6.4) |
| Obesity | 123 (6.2) | 86 (5.6) | .032 | 37 (8.5) |
| Systemic inflammatory disease | 115 (5.8) | 88 (5.7) | .73 | 27 (6.2) |
| Solid organ transplant recipient | 24 (1.2) | 17 (1.1) | .46 | 7 (1.6) |
| Cancer | 94 (4.7) | 69 (4.5) | .31 | 25 (5.7) |
| RAASi | 695 (35.1) | 524 (33.9) | .047 | 171 (39.1) |
| Alpha‐blocker | 18 (0.9) | 15 (1.0) | .78 | 3 (0.7) |
| Beta‐blocker | 430 (21.7) | 338 (21.9) | .74 | 92 (21.1) |
| Statins | 518 (26.1) | 384 (24.9 | .016 | 134 (30.7) |
| Immunosuppressants including glucocorticoids | 223 (11.3) | 167 (10.8) | .27 | 56 (12.8) |
| Oral anticoagulants | 130 (6.6) | 97 (6.3) | .38 | 33 (7.6) |
| Thrombocyte aggregation inhibitors | 279 (14.1) | 198 (12.8) | .003 | 81 (18.5) |
| Lopinavir/Ritonavir | 1 (0.1) | 1 (0.1) | 1.0 | 0 (0.0) |
| Anti HCV and/or Interferon | 1 (0.1) | 0 (0.0) | .22 | 1 (0.2) |
Data are presented as numbers with percentages or median with interquartile range as appropriate.
Abbreviations: COPD, chronic obstructive pulmonary disease; HCV, hepatitis C virus; ICU, intensive care unit; P, P‐value for difference between adjacent columns calculated by Fisher´s exact test or Mann‐Whitney U test as appropriate; RAASi, renin angiotensin aldosterone system inhibitors.
This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.